ORAL PROLONGED-ACTION DRUGS

被引:4
作者
HOLLISTER, LE
机构
来源
JOURNAL OF CHRONIC DISEASES | 1963年 / 16卷 / 10期
关键词
D O I
10.1016/0021-9681(63)90039-0
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
引用
收藏
页码:1039 / &
相关论文
共 10 条
[1]  
CAMPBELL J A, 1959, Can Med Assoc J, V81, P15
[2]  
CAMPBELL J A, 1957, Can Med Assoc J, V77, P602
[3]  
CHAPMAN DG, 1957, CAN MED ASSOC J, V76, P102
[4]   ORAL MEDICATION WITH PREPARATIONS FOR PROLONGED ACTION [J].
DRAGSTEDT, CA .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1958, 168 (12) :1652-1655
[5]   EVALUATION OF A SUSTAINED RELEASE FORM OF PHENYLPROPANOLAMINE HYDROCHLORIDE BY URINARY EXCRETION STUDIES [J].
HEIMLICH, KR ;
OBRIEN, PD ;
MACDONNELL, DR ;
FLANAGAN, TL .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1961, 50 (03) :232-&
[6]  
HOLLISTER LE, 1962, CURR THER RES CLIN E, V4, P471
[8]  
HOLLISTER LE, IN PRESS
[9]   ABSORPTION, TESTING, AND CLINICAL EVALUATION OF ORAL PROLONGED-ACTION DRUGS [J].
LAZARUS, J ;
COOPER, J .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1961, 50 (09) :715-+
[10]   PREPARATION OF A S-35 LABELLED TRIMEPRAZINE TARTRATE SUSTAINED ACTION PRODUCT FOR ITS EVALUATION IN MAN [J].
ROSEN, E ;
SWINTOSKY, JV .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1960, 12 :T237-T244